SeekingAlpha · Mar 6, 2026
Nutex Health Inc. (NUTX) Q4 2025 Earnings Call Transcript
Nutex Health Inc. (NUTX) Q4 2025 Earnings Call March 6, 2026 10:30 AM ESTCompany ParticipantsJennifer Rodriguez - Investor & Public Relations...
NU
NASDAQ · NUTX
Nutex Health, Inc.
Healthcare · Medical - Healthcare Information Services
$200.15
Down-$9.95 (-4.74%)
Updated Nov 2, 2026, 3:40 AM
SID Score
6.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.13B
- P/E ratio
- 11.18
- Dividend yield
- 0.00%
- 52-week range
- $83.99 – $226.16
- Volume
- 120.02K
- Avg. volume
- 149.38K
Price performance · NUTX
NUTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NUTX closed at $200.15 after 20 trading sessions, down 11.04% for the selected period.
- Last close
- $200.15
- Period change
- -11.04%
- Period low
- $186.10
- Period high
- $225.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $208.32 | $210.17 | $195.20 | $200.15 | 120.02K |
| Oct 29, 2026 | $212.95 | $215.97 | $209.01 | $210.10 | 79.56K |
| Oct 28, 2026 | $209.49 | $215.53 | $207.59 | $212.63 | 120.16K |
| Oct 27, 2026 | $210.26 | $212.43 | $203.89 | $208.25 | 128.13K |
| Oct 26, 2026 | $213.69 | $225.00 | $208.36 | $209.005 | 197.26K |
| Oct 23, 2026 | $202.70 | $213.815 | $202.70 | $209.59 | 128.91K |
| Oct 22, 2026 | $194.23 | $206.75 | $194.23 | $206.09 | 129.77K |
| Oct 21, 2026 | $199.75 | $200.335 | $195.46 | $197.61 | 73.58K |
| Oct 20, 2026 | $189.45 | $200.00 | $189.45 | $198.99 | 102.84K |
| Oct 19, 2026 | $190.63 | $192.89 | $188.09 | $191.25 | 79.7K |
| Oct 16, 2026 | $200.50 | $200.50 | $185.46 | $186.10 | 121.21K |
| Oct 15, 2026 | $192.64 | $203.64 | $182.90 | $200.80 | 141.36K |
| Oct 14, 2026 | $199.59 | $206.81 | $194.23 | $196.91 | 125.02K |
| Oct 13, 2026 | $206.05 | $209.70 | $203.07 | $204.36 | 141.02K |
| Oct 12, 2026 | $206.18 | $212.00 | $198.56 | $206.15 | 122.46K |
| Oct 9, 2026 | $204.69 | $210.45 | $203.615 | $206.29 | 171.21K |
| Oct 8, 2026 | $210.39 | $216.00 | $204.46 | $205.01 | 177.94K |
| Oct 7, 2026 | $214.18 | $222.00 | $210.685 | $213.02 | 237.11K |
| Oct 6, 2026 | $225.00 | $226.1575 | $217.46 | $218.40 | 122.79K |
| Oct 5, 2026 | $216.35 | $225.66 | $214.18 | $225.00 | 156.47K |
Latest NUTX news
The latest Smart Investors Daily articles mentioning NUTX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NUTX research
Overview
Company profile and research snapshot.
Company profile
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $205.00
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 26, 2026 | Ladenburg Thalmann | Buy | — |
| Sep 25, 2026 | Freedom Capital Markets | Buy | — |
| Sep 4, 2026 | B. Riley Securities | Buy | — |
| Aug 11, 2026 | Lake Street | Buy | — |
| Jun 26, 2026 | B. Riley Securities | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Mar 6, 2026
Nutex Health shares are trading lower after the company reported worse-than-expected Q4 financial results.
Benzinga · Mar 6, 2026
Market-Moving News for March 6th
MRVL: 15% | Marvell Technology shares are trading higher after the company reported better-than-expected Q4 financial results. IOT: 15% | Samsara shares are trading higher after the company
Benzinga · Mar 5, 2026
Nutex Health Announces $25M Share Buyback; Dates Not Disclosed
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
